admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

MYND Life Sciences Announces Collaborative Research Agreement with the University of...

atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for...

PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for...

Wesana Health Provides Strategic and Operational Updates

Field Trip Receives Notice of Allowance for US Patent Application Covering...

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel...

Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted...

PT283 – Greg McKee – Nociplastic Pain and Psychedelics

Psychedelic Research and Clinical Trials in 2021

1...166167168...218 Page 167 of 218

Spring 2025 Psychedelic Policy Update: Bills Hang in the Balance as...

Dr Simon Ruffell – Other Ways of Knowing

Dispatch from Breaking Convention 2025: Key Takeaways from Europe’s Largest Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin